Name /Formosa Pharmaceuticals Inc.,
Address /8F-6, No. 57, Fuxing N. Rd., Taipei City 105404, Taiwan
Name /Dr. Erick Co
Formosa Pharmaceuticals is a clinical stage biopharmaceutical company with focus in the therapeutic areas of ophthalmology, oncology, and anti-infectives.
Formosa Pharma's primary objectives are identifying regional/global licensing or co-development partners for our two leading assets:
APP13007: Phase 3 candidate for inflammation and pain after cataract surgery (Phase 2 summary is available).
TSY-0110: Biosimilar of the antibody-drug conjugate, ado-trastuzumab emtansine (Kadcyla).
Name /Wayne Wei